prednisone and Uveomeningoencephalitic Syndrome
prednisone has been researched along with Uveomeningoencephalitic Syndrome in 43 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Uveomeningoencephalitic Syndrome: A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Case report of a patient with Vogt-Koyanagi-Harada disease on prednisone, with acute clinical changes suspicious for bilateral tuberculous choroiditis." | 4.02 | TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE. ( Anderson, EW; El Khoury, L; Goldberg, NR; Jonisch, J; Schwartzman-Morris, JS, 2021) |
"Intensive and prolonged systemic treatment with corticosteroids is recommended for the patients with first attack of VKH syndrome, where as regular treatment with chlorambucil is useful for control of chronic and recurrent uveitis seen in VKH syndrome." | 3.71 | [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome]. ( Fu, T; Huang, X; Li, F; Wang, H; Yang, P; Zhong, H; Zhou, H, 2002) |
"A brazilian housewife, descendant of japanese (both parents), 37 years aged, affected with Vogt-Koyanagi's syndrome (uveitis, dysacousia, alopecia, madarosis, poliosis, vitiligo) was treated with prednisone." | 3.66 | [Vogt-Koyanagi syndrome. Therapeutic trial with corticosteroid]. ( Curban, GV; Kayano, T; Vieira Filho, E, 1979) |
"The visual results, frequency of recurrence of uveitis and incidence of ocular complications were compared between the two groups." | 2.70 | [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis]. ( Du, H; Hu, T; Liu, Q; Min, H; Zhang, M, 2002) |
"Oral prednisone was gradually tapered off by a diminished dose according to a relatively strict protocol." | 1.91 | HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT-KOYANAGI-HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN. ( Cheng, Z; Li, H; Li, X; Liu, T; Tao, Q; Wang, K; Zhang, M; Zhang, X; Zhao, G; Zheng, C, 2023) |
"He was found to have bilateral optic disc edema (ODE) and peripapillary subretinal fluid and was initially investigated for causes of raised intracranial pressure." | 1.62 | Headache and Bilateral Optic Disc Edema as the Initial Manifestation of Vogt-Koyanagi-Harada Disease. ( Christakis, PG; Micieli, JA; Nichani, P, 2021) |
"We describe a 55-year-old male IgA nephropathy patient who was admitted with high fever and hematuria." | 1.56 | A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome. ( Fan, X; Han, H; Tian, M; Zhang, Q, 2020) |
"To investigate the effectiveness, visual outcome, and prognostic factors of Vogt-Koyanagi-Harada (VKH) disease treatment with a reduced dose of corticosteroids combined with immunosuppressive agents." | 1.48 | Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. ( Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q, 2018) |
"To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease." | 1.46 | Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. ( Abu El-Asrar, AM; Al-Muammar, A; Dosari, M; Gikandi, PW; Hemachandran, S, 2017) |
"To analyse the rate of clinical recurrences in Brazilian patients with Vogt-Koyanagi-Harada (VKH) disease after early high-dose corticosteroid treatment." | 1.42 | High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. ( Costa, RA; da Silva, FT; Hirata, CE; Kalil, J; Marin, ML; Rodrigues, H; Sakata, VM; Yamamoto, JH, 2015) |
"To study the effectiveness of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease." | 1.38 | The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. ( Abu El-Asrar, AM; Al-Mezaine, HS; Al-Muammar, AM; Hemachandran, S; Kangave, D, 2012) |
"The case of VKH syndrome affecting Polish girl is very rare." | 1.33 | [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl]. ( Mańkowska, A; Swiech-Zubilewicz, A; Wróblewska, E, 2005) |
"The VKH syndrome has been reported to occur in association with other autoimmune disorders." | 1.32 | Vogt-Koyanagi-Harada syndrome and ulcerative colitis. ( Federman, DG; Judson, PH; Kirsner, RS; Kravetz, JD; Ruser, CB, 2004) |
Research
Studies (43)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.65) | 18.7374 |
1990's | 6 (13.95) | 18.2507 |
2000's | 10 (23.26) | 29.6817 |
2010's | 20 (46.51) | 24.3611 |
2020's | 5 (11.63) | 2.80 |
Authors
Authors | Studies |
---|---|
Wang, K | 1 |
Zheng, C | 1 |
Zhao, G | 1 |
Zhang, M | 2 |
Liu, T | 1 |
Li, H | 1 |
Tao, Q | 1 |
Cheng, Z | 1 |
Li, X | 1 |
Zhang, X | 1 |
Nichani, P | 1 |
Christakis, PG | 1 |
Micieli, JA | 1 |
Li, AS | 1 |
Tang, PH | 1 |
Do, DV | 1 |
Zhang, Q | 1 |
Fan, X | 1 |
Tian, M | 1 |
Han, H | 1 |
Urzua, CA | 2 |
Guerrero, J | 2 |
Gatica, H | 1 |
Velasquez, V | 2 |
Goecke, A | 2 |
Tsui, E | 1 |
Bottini, A | 1 |
Ghadiali, Q | 1 |
Balaratnasingam, C | 1 |
Barbazetto, I | 1 |
Yang, P | 2 |
Ye, Z | 1 |
Du, L | 1 |
Zhou, Q | 1 |
Qi, J | 1 |
Liang, L | 1 |
Wu, L | 1 |
Wang, C | 1 |
Kijlstra, A | 1 |
Birnbaum, FA | 1 |
Finn, AP | 1 |
Jaffe, GJ | 1 |
Anderson, EW | 1 |
El Khoury, L | 1 |
Schwartzman-Morris, JS | 1 |
Jonisch, J | 1 |
Goldberg, NR | 1 |
Chen, P | 1 |
Chaigne-Delalande, B | 1 |
Liu, B | 1 |
Anguita, R | 1 |
Sabat, P | 1 |
Sen, HN | 1 |
Lee, RWJ | 1 |
Caso, F | 1 |
Rigante, D | 1 |
Vitale, A | 1 |
Costa, L | 1 |
Bascherini, V | 1 |
Latronico, E | 1 |
Franceschini, R | 1 |
Cantarini, L | 1 |
Alp, A | 1 |
Akdam, H | 1 |
Akar, H | 1 |
Koseoglu, K | 1 |
Ozkul, A | 1 |
Meteoglu, I | 1 |
Yenicerioglu, Y | 1 |
Sakata, VM | 2 |
da Silva, FT | 2 |
Hirata, CE | 2 |
Marin, ML | 1 |
Rodrigues, H | 1 |
Kalil, J | 1 |
Costa, RA | 1 |
Yamamoto, JH | 2 |
Morita, C | 1 |
Rodriguez, EE | 1 |
Abdallah, SF | 1 |
Lavezzo, MM | 1 |
Machado, CG | 1 |
Oyamada, MK | 1 |
Abu El-Asrar, AM | 2 |
Dosari, M | 1 |
Hemachandran, S | 2 |
Gikandi, PW | 1 |
Al-Muammar, A | 1 |
Manethova, K | 1 |
Ernest, J | 1 |
Hrevus, M | 1 |
Vinh, T | 1 |
Elia, M | 1 |
Kawaguchi, T | 1 |
Horie, S | 1 |
Bouchenaki, N | 1 |
Ohno-Matsui, K | 1 |
Mochizuki, M | 1 |
Herbort, CP | 1 |
Cuchacovich, M | 1 |
Solanes, F | 1 |
Díaz, G | 1 |
Cermenati, T | 1 |
Avila, S | 1 |
Verdaguer, J | 1 |
Verdaguer, JI | 1 |
Carpentier, C | 1 |
Stopel, J | 1 |
Rojas, B | 1 |
Traipe, L | 1 |
Gallardo, P | 1 |
Sabugo, F | 1 |
Zanoli, M | 1 |
Merino, G | 1 |
Villarroel, F | 1 |
Tang, Y | 1 |
Wang, X | 1 |
Ding, Y | 1 |
Li, C | 1 |
Jia, J | 1 |
Lee, GE | 1 |
Lee, BW | 1 |
Rao, NA | 4 |
Fawzi, AA | 1 |
Arias, L | 1 |
Alcubierre, R | 1 |
Lorenzo, D | 1 |
Nazari, H | 1 |
Al-Mezaine, HS | 1 |
Kangave, D | 1 |
Al-Muammar, AM | 1 |
Sifuentes Giraldo, WA | 1 |
de la Puente Bujidos, C | 1 |
de Blas Beorlegui, G | 1 |
López San Román, A | 1 |
Peña Arrebola, A | 1 |
Wang, H | 1 |
Zhou, H | 1 |
Zhong, H | 2 |
Li, F | 1 |
Huang, X | 1 |
Fu, T | 1 |
Liu, Q | 1 |
Min, H | 1 |
Du, H | 1 |
Hu, T | 1 |
Tian'en, Z | 1 |
Libin, D | 1 |
Yushu, T | 1 |
BRONSTEIN, M | 1 |
Federman, DG | 1 |
Kravetz, JD | 1 |
Ruser, CB | 1 |
Judson, PH | 1 |
Kirsner, RS | 1 |
Kohnen, EM | 1 |
Pansdorf, Y | 1 |
Zubcov, A | 1 |
Swiech-Zubilewicz, A | 1 |
Wróblewska, E | 1 |
Mańkowska, A | 1 |
Goldstein, DA | 1 |
Tessler, HH | 2 |
Read, RW | 1 |
Yu, F | 1 |
Accorinti, M | 1 |
Bodaghi, B | 1 |
Chee, SP | 1 |
Fardeau, C | 1 |
Goto, H | 1 |
Holland, GN | 1 |
Kawashima, H | 1 |
Kojima, E | 1 |
Lehoang, P | 1 |
Lemaitre, C | 1 |
Okada, AA | 1 |
Pivetti-Pezzi, P | 1 |
Secchi, A | 1 |
See, RF | 1 |
Tabbara, KF | 1 |
Usui, M | 1 |
Cunningham, ET | 1 |
Demetrius, R | 1 |
Frieden, IJ | 1 |
Emery, HM | 1 |
Irvine, AR | 1 |
Good, WV | 1 |
Lepvrier-Guibal, N | 1 |
Korobelnik, JF | 1 |
Xuan, TH | 1 |
Wiesli, P | 1 |
Bernauer, W | 1 |
Furrer, J | 1 |
Mikou, O | 1 |
Chiheb, S | 1 |
Zouhair, K | 1 |
Jarmouni, RI | 1 |
Nejjam, F | 1 |
El Ouazzani, T | 1 |
Amraoui, A | 1 |
Lakhdar, H | 1 |
Garcia-Valenzuela, E | 1 |
Carnahan, M | 1 |
Ryan, JJ | 1 |
Oldstein, DA | 1 |
Curban, GV | 1 |
Kayano, T | 1 |
Vieira Filho, E | 1 |
Kätterer, C | 1 |
Kaeser, HE | 1 |
Steiger, U | 1 |
Forster, DJ | 1 |
Green, RL | 1 |
Johnston, CA | 1 |
Teitelbaum, CS | 1 |
Clinical Trials (2)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study[NCT03399175] | 40 participants (Anticipated) | Interventional | 2015-03-23 | Recruiting | |||
Multimodal Analysis and Electroretinogram in VKH From Acute Onset - a Prospective Study[NCT03811366] | 12 participants (Actual) | Interventional | 2011-06-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
3 reviews available for prednisone and Uveomeningoencephalitic Syndrome
Article | Year |
---|---|
Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
Topics: Acute Disease; Anti-Inflammatory Agents; Fluorescein Angiography; Fluorescence; Fundus Oculi; Humans | 2011 |
[Vogt-Koyanagi-Harada disease complicated by subretinal neovessels].
Topics: Adult; Female; Humans; Prednisone; Retinal Detachment; Retinal Neovascularization; Uveomeningoenceph | 1995 |
[Rare form of uveitis with neurological symptoms: the Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
Topics: Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Middle Aged; P | 1992 |
Trials
2 trials available for prednisone and Uveomeningoencephalitic Syndrome
Article | Year |
---|---|
Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dose-Respon | 2010 |
[Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
Topics: Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Prog | 2002 |
Other Studies
38 other studies available for prednisone and Uveomeningoencephalitic Syndrome
Article | Year |
---|---|
HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT-KOYANAGI-HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN.
Topics: Acute Disease; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Prednisone; R | 2023 |
Headache and Bilateral Optic Disc Edema as the Initial Manifestation of Vogt-Koyanagi-Harada Disease.
Topics: Adult; Diagnosis, Differential; Glucocorticoids; Headache; Humans; Male; Papilledema; Prednisone; Sl | 2021 |
Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
Topics: Administration, Oral; Blindness; Glucocorticoids; Headache; Humans; Infusions, Intravenous; Male; Me | 2020 |
A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
Topics: Cyclophosphamide; Fluorescein Angiography; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunos | 2020 |
Evaluation of the Glucocorticoid Receptor as a Biomarker of Treatment Response in Vogt-Koyanagi-Harada Disease.
Topics: Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Hum | 2017 |
Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Topics: Fluorescein Angiography; Glucocorticoids; Humans; Male; Middle Aged; Multimodal Imaging; Ophthalmosc | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein | 2018 |
Bilateral Retinal Detachments Presenting With Acute Angle Closure.
Topics: Female; Fluorescein Angiography; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Intraocular Press | 2018 |
TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE.
Topics: Adult; Antitubercular Agents; Choroiditis; Female; Glucocorticoids; Humans; Interferon-gamma Release | 2021 |
Glucocorticoid Receptor-α and MKP-1 as Candidate Biomarkers for Treatment Response and Disease Activity in Vogt-Koyanagi-Harada Disease.
Topics: Adult; Biomarkers; Dual Specificity Phosphatase 1; Female; Gene Expression Regulation; Glucocorticoi | 2019 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report.
Topics: Adult; Amaurosis Fugax; Aneurysm; Brain Edema; Celiac Artery; Combined Modality Therapy; Humans; Hyp | 2014 |
High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
Topics: Adolescent; Adult; Brazil; Child; Chronic Disease; Female; Fibrosis; Fluorescein Angiography; Glucoc | 2015 |
Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adult; Biomarkers; Coloring Agents; Drug Combinations; Female; Fluorescein Ang | 2016 |
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Disease Progression; Drug Therapy, Co | 2017 |
Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Topics: Adult; Choroid; Fluorescein Angiography; Glucocorticoids; Humans; Male; Ophthalmoscopy; Prednisone; | 2017 |
Headaches and Blurry Vision.
Topics: Adult; Fluorescein Angiography; Glucocorticoids; Headache; Humans; Male; Prednisone; Retinal Detachm | 2017 |
Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Choroid; Disease Progression; | 2010 |
Longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Anti-Inflammatory Agents; Atrophy; Cyclophosphamide; Cyclosporine; Dysuria; Female; Huma | 2010 |
[Bullous retinal detachment in chronic central serous chorioretinopathy treated with photodynamic therapy].
Topics: Adult; Blister; Central Serous Chorioretinopathy; Chronic Disease; Cyclosporine; Diagnosis, Differen | 2011 |
Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up S | 2012 |
The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Coloring Agents; Drug Therapy, Combin | 2012 |
Herpes zoster motor neuropathy in a patient with previous motor paresis secondary to Vogt-Koyanagi-Harada disease.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Disease Progression; Electromyography; Female; Herpes Zost | 2013 |
[Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
Topics: Adolescent; Adult; Child; Chlorambucil; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Me | 2002 |
Vogt-Koyanagi-Harada syndrome: report of a juvenile case.
Topics: Child; China; Follow-Up Studies; Humans; Male; Prednisone; Rare Diseases; Risk Assessment; Severity | 2003 |
Vogt-Koyanagi-Harada disease; treatment with prednisone.
Topics: Humans; Prednisone; Uveitis; Uveomeningoencephalitic Syndrome | 1957 |
Vogt-Koyanagi-Harada syndrome and ulcerative colitis.
Topics: Adult; Alopecia; Colitis, Ulcerative; Glucocorticoids; Humans; Male; Prednisone; Uveomeningoencephal | 2004 |
[Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
Topics: Azathioprine; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2004 |
[The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
Topics: Anti-Inflammatory Agents; Child; Female; Humans; Injections, Intravenous; Prednisone; Uveomeningoenc | 2005 |
Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.
Topics: Anti-Bacterial Agents; Brucella; Brucellosis; Choroiditis; Dexamethasone; Doxycycline; Drug Therapy, | 2006 |
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans | 2006 |
Vogt-Koyanagi-Harada syndrome in a 4-year old child.
Topics: Alopecia; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Blindness; Child, Preschool; | 1995 |
Headache and bilateral visual loss in a young hypothyroid Indian man.
Topics: Adult; Autoimmune Diseases; Headache; Humans; Hypothyroidism; Male; Prednisone; Thyroxine; Uveomenin | 1999 |
[Vogt-Koyanagi-Harada's disease: 3 cases].
Topics: Adult; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Female; Follow-Up Studies; Humans; | 2000 |
Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease.
Topics: Adult; Exudates and Transudates; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Hum | 2000 |
[Vogt-Koyanagi syndrome. Therapeutic trial with corticosteroid].
Topics: Adult; Drug Evaluation; Female; Humans; Pigmentation Disorders; Prednisone; Tablets; Uveitis; Uveome | 1979 |
Unilateral manifestation of the Vogt-Koyanagi-Harada syndrome in a 7-year-old child.
Topics: Child; Fluorescein Angiography; Fundus Oculi; Humans; Male; Prednisone; Uveomeningoencephalitic Synd | 1991 |
Magnetic resonance imaging in Vogt-Koyanagi-Harada syndrome.
Topics: Administration, Oral; Adult; Chlorambucil; Diagnosis, Differential; Female; Humans; Magnetic Resonan | 1990 |